Connect with us

Health

European Nations and Non-Profits Pledge $700 Million to WHO for Global Health Initiatives

Published

on

Berlin, Germany – A coalition of European countries and non-profit organizations has committed $700 million (€627.4 million) to the World Health Organization (WHO) to support its efforts in tackling global health challenges. The announcement was made at the World Health Summit in Berlin, as the WHO pushes for more financial flexibility in how it allocates its resources.

This new funding, combined with an earlier pledge of $300 million (€268.9 million) from the European Union and the African Union, brings the total contribution to $1 billion (€896.3 million). The funds will be used by the WHO to combat preventable diseases and target 40 million preventable deaths over the next four years.

Germany emerged as the largest contributor, pledging nearly $400 million (€358.5 million), including $262.6 million (€234.8 million) in new money. Other European countries, including Norway, Luxembourg, Denmark, and Ireland, also made significant contributions. These funds are seen as crucial in providing the WHO with the financial stability it needs to respond to global health crises and long-term health challenges.

WHO’s Push for Flexible Funding

Historically, the WHO’s funding has come from a mix of member state contributions and voluntary donations from governments and non-profits. Much of this money is earmarked for specific health programs, limiting the organization’s ability to allocate resources as needed. This has made it difficult for the WHO to retain staff, plan long-term initiatives, or pivot quickly in the face of emergencies like the COVID-19 pandemic.

To address these challenges, countries agreed in 2022 to increase their membership dues to cover 50% of the WHO’s core budget by 2030, up from just 13% in 2022. This move aims to ensure the organization has a more predictable and flexible financial foundation.

See also  US Tariffs on Pharmaceuticals Could Spark Global Trade Disruptions

At the summit, German Chancellor Olaf Scholz emphasized the importance of this shift. “The WHO’s work benefits us all. What it needs for this work is sustainable financing that gives it the certainty to plan ahead and the flexibility to react,” he said.

European Support for Global Health

European Commission President Ursula von der Leyen described the WHO as the world’s “collective first line of defence against health crises and inequalities.” She highlighted the EU’s €250 million investment announced earlier this year to address global health issues, including mpox, cholera, and the Marburg virus. Additionally, von der Leyen committed over €75 million to support the WHO’s mRNA technology hub in South Africa, which aims to boost vaccine production in low- and middle-income countries.

Non-Profits and Pharmaceutical Companies Join the Effort

Several global health non-profits, including Wellcome, Resolve to Save Lives, and the World Diabetes Foundation, pledged more than $130 million (€116.5 million) to support the WHO. Pharmaceutical companies Sanofi, Boehringer Ingelheim, and Novo Nordisk also committed to backing the organization’s efforts.

WHO Director-General Dr. Tedros Adhanom Ghebreyesus expressed gratitude for the contributions but acknowledged the challenging financial environment. “We know that we are making this ask at a time of competing priorities and limited resources,” he said, adding, “every contribution counts.”

The WHO is expected to seek further commitments during the upcoming G20 summit in Brazil, as it continues to bolster its financial capacity to address global health threats.

Health

Study Finds AI Systems Can Repeat Fake Medical Claims When Framed Credibly

Published

on

“Large language models accept fake medical claims if presented as realistic in medical notes and social media discussions, a study has found.”

As more people turn to the internet to research symptoms, compare treatments and share personal health experiences, artificial intelligence tools are increasingly being used to answer medical questions. A new study warns that many of these systems remain vulnerable to medical misinformation, particularly when false claims are presented in authoritative or realistic language.

The findings, published in The Lancet Digital Health, show that leading artificial intelligence systems can mistakenly repeat incorrect medical information when it appears in formats that resemble professional healthcare documents or trusted online discussions. Researchers analysed how large language models respond when faced with false medical statements written in a credible tone.

The study examined responses from 20 widely used language models, including systems developed by OpenAI, Meta, Google, Microsoft, Alibaba and Mistral AI, as well as several models specifically fine-tuned for medical use. In total, researchers assessed more than one million prompts designed to test whether AI would accept or reject fabricated health information.

Fake statements were inserted into real hospital discharge notes, drawn from common health myths shared on Reddit, or embedded in simulated clinical scenarios written to resemble authentic healthcare guidance. Across all models tested, incorrect information was accepted around 32 percent of the time. Performance varied significantly, with smaller or less advanced models accepting false claims in more than 60 percent of cases, while more advanced systems, including ChatGPT-4o, did so in roughly 10 percent of responses.

See also  United States Officially Withdraws from World Health Organization After Year of Controversial Health Policy

The researchers also found that medical fine-tuned models performed worse than general-purpose systems, raising concerns about tools designed specifically for healthcare use.

“Our findings show that current AI systems can treat confident medical language as true by default, even when it’s clearly wrong,” said Eyal Klang of the Icahn School of Medicine at Mount Sinai, one of the study’s senior authors. He added that how a claim is written often matters more to the model than whether it is accurate.

Some of the accepted misinformation could pose real risks to patients. Several models endorsed claims such as Tylenol causing autism during pregnancy, rectal garlic boosting immunity, mammograms causing cancer, and tomatoes thinning blood as effectively as prescription medication. In another case, a discharge note incorrectly advised patients with oesophageal bleeding to drink cold milk, which some models repeated without flagging safety concerns.

The study also tested how AI systems responded to flawed arguments known as fallacies. While many fallacies prompted scepticism, models were more likely to accept false claims framed as expert opinions or warnings of catastrophic outcomes.

Researchers say future work should focus on measuring how often AI systems pass on falsehoods before they are used in clinical settings. Mahmud Omar, the study’s first author, said the dataset could help developers and hospitals stress-test AI tools and track improvements over time.

The authors said stronger safeguards will be essential as AI becomes more deeply embedded in healthcare decision-making.

Continue Reading

Health

Moderate Caffeine Intake Linked to Lower Dementia Risk, Study Finds

Published

on

“Moderate daily consumption of caffeine is associated with a lower risk of dementia and slower cognitive decline, according to a new study.”

Drinking coffee or tea on a regular basis may help support healthy brain ageing, researchers reported, adding to growing evidence that lifestyle and dietary factors can influence cognitive health later in life. The findings suggest that moderate caffeine intake could play a modest role in reducing the risk of dementia and preserving cognitive function over time.

The study, published in JAMA, found that consuming two to three cups of caffeinated coffee or one to two cups of tea per day was associated with up to an 18% lower risk of developing dementia. The strongest benefits were seen among participants with moderate caffeine intake, though higher levels of consumption did not appear to cause harm and showed similar protective effects.

“When searching for possible dementia prevention tools, we thought something as prevalent as coffee may be a promising dietary intervention,” said senior author Daniel Wang, an associate scientist at the Mass General Brigham Department of Medicine and an assistant professor at Harvard Medical School.

Researchers analysed data from more than 130,000 participants who underwent repeated dietary, cognitive and dementia assessments. The participants were followed for as long as 43 years, allowing the team to assess long-term patterns of coffee and tea consumption and their potential impact on cognitive health. During the follow-up period, 11,033 participants developed dementia.

The analysis showed that both men and women with the highest caffeine intake had an 18% lower risk of dementia compared with those who consumed little or no caffeine. Coffee drinkers also reported fewer symptoms of subjective cognitive decline, defined as self-perceived memory loss or confusion, with rates of 7.8% compared with 9.5% among those who drank less coffee.

See also  Europe Debates Social Media Limits as Experts Urge Parents to Help Children Build Healthier Digital Habits

Scientists believe that coffee and tea may offer neuroprotective benefits due to bioactive compounds such as caffeine and polyphenols. These substances are thought to reduce inflammation and cellular damage, while supporting blood vessel health in the brain. Previous studies have also linked caffeine consumption to improved insulin sensitivity and better vascular function, both of which are associated with cognitive health.

The authors cautioned that the research was observational and cannot prove a direct cause-and-effect relationship. The study also did not differentiate between types of coffee or tea, or account for variations in preparation methods, including roast levels, origins or brewing techniques.

The researchers noted that early prevention remains crucial, as current dementia treatments provide limited benefit once symptoms develop. Dementia typically progresses from subjective cognitive decline to mild cognitive impairment before advancing to clinical dementia.

While the findings are encouraging, the authors stressed that caffeine consumption is only one of several factors that may help protect cognitive function with age. “Our study suggests that caffeinated coffee or tea consumption can be one piece of that puzzle,” Wang said.

Continue Reading

Health

Growing Research Links Tattoos to Possible Cancer Risks, Experts Say

Published

on

Tattoos are more popular than ever, but a growing body of research suggests a connection between permanent ink and certain types of cancer. How concerned should the public be?

From tribal sleeves to lower-back butterflies, humans have been inking their skin for thousands of years. For most, the main concern has been the fear of future regrets. However, recent studies suggest that tattoos could carry more serious long-term health risks.

The popularity of tattoos has risen sharply in recent years. Research published in the European Journal of Public Health estimates that between 13 and 21 percent of people in Western Europe now have at least one tattoo. Despite this prevalence, relatively little is known about the potential long-term effects of permanent ink.

Previous studies have shown that tattoo pigments can accumulate in the lymph nodes, sometimes causing inflammation and, in rare cases, lymphoma—a type of blood cancer. A 2025 study by the University of Southern Denmark (SDU) expanded on this, reporting that individuals with tattoos may face higher risks of skin cancer and lymphoma. Using a cohort of randomly selected twins, the researchers found that tattooed participants had nearly four times the risk of skin cancer compared with their non-tattooed siblings.

The study also suggested that tattoo size could affect risk, with designs larger than the palm associated with higher hazard rates.

“We have evidence that there is an association [between the amount of ink and risk] for lymphoma and for skin cancer,” said Signe Bedsted Clemmensen, co-author of the study and assistant professor of biostatistics at SDU. “For lymphoma, the hazard rate is 2.7 times higher, so this is quite a lot. And for skin cancers, before it was 1.6 and now it’s 2.4. This indicates that the more ink you have, the higher the risk, the higher the hazard rate.”

See also  Global Health Inequities Persist as Progress on Life Expectancy and Mortality Slows, Says WHO

Clemmensen emphasized that these findings remain preliminary, with many variables—including ink types, tattoo placement, and genetic and environmental factors—still under investigation. “The bottom line is, more research is needed,” she said. “But also, the next step I think is studying the biological mechanisms [of getting tattooed] and trying to understand what happens there.”

Experts also note other risks unrelated to cancer. Tattoo inks consist of pigments combined with a carrier fluid to deposit color into the dermis. Some inks, often imported, can contain trace amounts of heavy metals such as nickel, chromium, cobalt, and lead, which can trigger allergic reactions or immune sensitivity. In 2022, the European Union restricted more than 4,000 hazardous substances in tattoo inks under its REACH regulations.

While tattoos are generally considered safe when applied hygienically, the long-term health consequences remain uncertain. “It’s up to each of us how we choose to live our lives, right? But as a researcher, it’s also my job to inform people of these risks,” Clemmensen said. “Or, when it comes to tattooing, right now it’s more about informing people about how little we know.”

Continue Reading

Trending